Literature DB >> 3886335

Long-term results of corneal transplantations in keratoconus patients.

J G de Lavalette, A R de Lavalette, G van Rij, W H Beekhuis, J A de Beijer-Dominicus.   

Abstract

In this retrospective study all 86 corneal transplantations performed for keratoconus in the Rotterdam Eye Hospital between 1969 and 1978 were included. Sixty seven perforating and 19 lamellar corneal grafts had been performed. The average follow-up was 59 months. Immune reactions occurred 12 times in 11 eyes with a perforating corneal graft (16%); in no case did this lead to permanent opacities in the graft. The visual result of the perforating graft is in general better than that of the lamellar graft. A lamellar graft is indicated, in our opinion, when the risk of trauma is high and the opportunities for follow-up insufficient, and when the peripheral cornea is markedly thin. In most cases we prefer a perforating graft because the results are better.

Entities:  

Mesh:

Year:  1985        PMID: 3886335     DOI: 10.1007/bf00162016

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  4 in total

1.  Graft reactions after keratoplasty for keratoconus.

Authors:  J W Chandler; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1974-04       Impact factor: 5.258

2.  Long term results of corneal grafting in keratoconus.

Authors:  N Ehlers; T Olsen
Journal:  Acta Ophthalmol (Copenh)       Date:  1983-10

3.  Lamellar keratoplasty in the treatment of keratoconus: conectomy.

Authors:  A R Gasset
Journal:  Ophthalmic Surg       Date:  1979-02

4.  The prognosis for keratoplasty in keratoconus.

Authors:  P G Paglen; M Fine; R L Abbott; R G Webster
Journal:  Ophthalmology       Date:  1982-06       Impact factor: 12.079

  4 in total
  2 in total

1.  Penetrating keratoplasty for keratoconus: visual and graft survival outcomes.

Authors:  Mansour M Al-Mohaimeed
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

2.  When is a tissue-typed cornea necessary?

Authors:  C C Kok-van Alphen; H J Völker-Dieben; J D'Amaro
Journal:  Doc Ophthalmol       Date:  1987 Sep-Oct       Impact factor: 2.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.